Early Vascular Aging (EVA): New Directions in Cardiovascular Protection brings together the last decade of research related to the characterization of EVA, as well as the predictive power of pulse wave velocity (PWV).

Chapter 1: Historical Aspects and Biology of AgingChapter 2: Cellular and Molecular Determinant of Arterial AgingChapter 3: Changing Demography of Europe-Greying PopulationsChapter 4: Population-Based StudiesChapter 5: Lessons from Amsterdam Growth and Health Longitudinal StudyChapter 6: History and Findings of the BLSAChapter 7: Changes in Peripheral Blood Pressure with Normal and Accelerated AgingChapter 8: Changes in Arterial Stiffness with Normal and Accelerated AgingChapter 9: Changes in Central Hemodynamics, Wave Reflection and Heart-Vessel Coupling with Normal and Accelerated AgingChapter 10: Early Aging of Endothelial Function and Platelet-Vessel Wall InteractionChapter 11: The Cross-Talk between the Macro and MicrocirculationChapter 12: Blood Pressure VariabilityChapter 13: Early Vascular Aging in Children with Low Birth Weight and/or PrematurityChapter 14: Age-Induced Endothelial Dysfunction and Intima-Media ThickeningChapter 15: Glucose Metabolism, Diabetes, and the Arterial WallChapter 16: Chronic Inflammation and AntherosclerosisChapter 17: Early and Late Stages of Chronic Kidney Disease in relation to Arterial ChangesChapter 18: Polycystic Ovarian SyndromeChapter 19: Early and Late Stages of Brain DamageChapter 20: Telomere Biology and Aging Chapter 21: Traditional versus new models of Risk PredictionChapter 22: Imaging Biomarkers: Aortic Stiffness and Carotid IMT as Predictors of CV DiseaseChapter 23: Genetic Markers in Prediction of CV DiseaseChapter 24: Vascular Aging and CV DiseaseChapter 25: Lifestyle Intervention: What works?Chapter 26: Targeting BP Lowering and Sympathetic Nervous SystemChapter 27: Targeting Central BP through the Macro-Microcirculation Cross-TalkChapter 28: Treatment of Abnormalities in Glucose and Lipid MetabolismChapter 29: New Drugs under Development for Cardiovascular PreventionChapter 30: Interventions to retard Biological Aging to be ExploredChapter 31: Immuniziation, Vaccines and Immunomodulation